San Mateo, CA, United States of America

Kurt Jarnigan

This inventor holds 1 USPTO granted patent. Top assignee: Entelos, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt Jarnigan. Retrieved from https://idiyas.com/inventor/kurt-jarnigan-ihmtptux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kurt Jarnigan: Innovator in Drug Signature Prediction

Introduction

Kurt Jarnigan is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of drug discovery through his innovative methods. His work focuses on predicting the biological activity of compounds, which is crucial for the development of new pharmaceuticals.

Latest Patents

Kurt Jarnigan holds a patent for a method titled "Signature Projection Score." This patent discloses a technique for predicting the biological activity of a compound by comparing its drug signature score to those of a plurality of known drug signatures. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Kurt is currently employed at Entelos, Inc., a company that specializes in predictive biology and drug development. His role at Entelos allows him to apply his innovative ideas in a practical setting, contributing to advancements in the pharmaceutical industry.

Collaborations

Throughout his career, Kurt has collaborated with several professionals, including Barrett P. Eynon and Georges Natsoulis. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Kurt Jarnigan is a pioneering inventor whose work in drug signature prediction is paving the way for advancements in pharmaceutical research. His contributions are vital for the future of drug development and biological activity prediction.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…